Mark Landon, MD
- Maternal Fetal Medicine
Appointments: (614) 293-2222
About MeI practice in obstetrics and gynecology, specializing in high-risk pregnancy. This includes an emphasis on diabetes in pregnancy. My focus on maternal fetal medicine involves treating these and other medical complications that can happen during pregnancy.
My goal is to inform my patients about various aspects of their care. I am also an advocate for birth options such as vaginal delivery after cesarean section. I believe in providing patients with comprehensive care while listening and providing answers to questions that may arise.
The people at The Ohio State University Wexner Medical Center are among the many things I appreciate about working here. I am blessed to work with a team of talented and committed individuals who put patients first.
When I'm not at work, I like to relax with my family, attend Ohio State football games and travel. I run five times per week, but I am getting a bit slower as I grow older!
- Named to the Castle Connolly list of America’s “Top Doctors” for 2015
- Co-principal investigator, national Maternal Fetal Medicine Unit Networks
- Principal investigator for nation's largest clinical trial for gestational diabetes mellitus (GDM) treatment
- Principal investigator for nation's largest vaginal birth after cesarean (VBAC) study
- Named to the Castle Connolly list of America’s “Top Doctors” for 2017
Specialties and conditions I treat
- Maternal Fetal Medicine
- Diabetes Mellitus
- Pregnancy Complications
- Preconception Care
- Pregnancy, High-Risk
- Diabetes, Gestational
Locations where I practice
Education and training
Cornell University Medical College
Obstetrics / Gynecology
University of Pennsylvania Medical Center
1/1/1980 - 1/1/1984
More about my work
American Board of OB/GYN
American Board of OB/GYN (Subspecialty: Maternal & Fetal Medicine)
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Landon has reported no financial relationships with medical device, research and/or drug companies.